FacultyFaculty/Author Profile
Pauline Farmer-Koppenol

Pauline Farmer-Koppenol

Bio-Rad Laboratories, Inc.
Associate General Counsel - Patents
Hercules, CA, USA


Pauline Farmer-Koppenol is Associate General Counsel – Patents for Bio-Rad Laboratories’ Clinical Diagnostics Group. In that role she manages CDG’s patent portfolio which covers instruments, diagnostic assays and controls. In addition, she advises the research and development units on intellectual property matters generally and negotiates research-related agreements as well as patent licenses. Prior to joining Bio-Rad in 2014, Pauline was an associate at Fenwick & West LLP where she represented life science and software clients. Her practice at Fenwick ranged from patent prosecution, patent portfolio analysis, intellectual property strategy counseling and negotiating research agreements and patent licenses.
Pauline Farmer-Koppenol is associated with the following items:
CHB Chapters  CHB Chapters United States Patent and Trademark Office, Nature-Based Product Examples 9-18 (Issued December 16, 2014) - Advanced Patent Prosecution Workshop 2017: Claim Drafting & Amendment Writing, Thursday, September 14, 2017
Drafting Patent Eligible Claims That Are Useful in Enforcement - Advanced Patent Prosecution Workshop 2017: Claim Drafting & Amendment Writing, Thursday, September 14, 2017
Eli Lilly and Company v. Teva Parenteral Medicines, Inc., APP Pharmaceuticals LLC, Pliva Hrvatska D.O.O., Teva Pharmaceuticals USA, Inc., Barr Laboratories, Inc., 2015-2067 (Fed. Cir. 2017) - Advanced Patent Prosecution Workshop 2017: Claim Drafting & Amendment Writing, Thursday, September 14, 2017
Ariosa Diagnostics, Inc., Natera, Inc., DNA Diagnostics Center, Inc. v. Sequenom, Inc., Sequenom Center for Molecular Medicine, LLC, ISIS Innovation Limited, 2014-1139, 2014-1144 (Fed. Cir. 2015) - Advanced Patent Prosecution Workshop 2017: Claim Drafting & Amendment Writing, Thursday, September 14, 2017
Rapid Litigation Management Ltd., Formerly Celsis Holdings, Inc., In Vitro, Inc. v. Cellzdirect, Inc., a Delaware Corporation and Wholly-Owned Subsidiary, Invitrogen Corporation, a Delaware Corporation, 2015-1570 (Fed. Cir. 2016) - Advanced Patent Prosecution Workshop 2017: Claim Drafting & Amendment Writing, Thursday, September 14, 2017
In re BRCA1- and BRCA2-Based Hereditary Cancer Test Patent Litigation, 2014-1361, -1366 (Fed. Cir. 2014) - Advanced Patent Prosecution Workshop 2017: Claim Drafting & Amendment Writing, Thursday, September 14, 2017
Live Seminar  Live Seminar Advanced Patent Prosecution Workshop 2018: Claim Drafting & Amendment Writing, Thursday, August 16, 2018, San Francisco, CA
Share
Email

  • FOLLOW PLI:
  • twitter
  • LinkedIn
  • GooglePlus
  • RSS

All Contents Copyright © 1996-2017 Practising Law Institute. Continuing Legal Education since 1933.

© 2017 PLI PRACTISING LAW INSTITUTE. All rights reserved. The PLI logo is a service mark of PLI.